×

Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues

  • US 9,909,189 B2
  • Filed: 11/17/2015
  • Issued: 03/06/2018
  • Est. Priority Date: 09/29/1999
  • Status: Expired due to Fees
First Claim
Patent Images

1. A cDNA molecule encoding a differentially expressed prostate cancer antigen 3 (PCA3) mRNA containing an additional sequence between exon 3and exon 4a, thereby giving rise to a long PCA3 mRNA, wherein the additional sequence is at least 90% identical to the sequence of positions 27-254 of SEQ ID NO:

  • 1 or the complement thereof.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×